Institutional Ownership Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY). We have compiled data on the 92 institutions that hold shares in the stock, with a total of 49 Million shares, which have been reported (via 13F filing form) to have a value of $236 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Parkman Healthcare Partners LLC
Stamford, CT |
May 15, 2024 Q1 2024 |
222,943
shares
|
$1.07 Million
0.23% of portfolio
|
Q1 2024
Added 4.95%
|
|
Overbrook Management Corp
New York, NY |
Apr 15, 2024 Q1 2024 |
219,326
shares
|
$1.06 Million
0.45% of portfolio
|
Q4 2022
Added 216.37%
|
|
Ubs Oconnor LLC
Chicago, IL |
May 15, 2024 Q1 2024 |
183,218
shares
|
$883,110
0.09% of portfolio
|
Q1 2024
Reduced 25.2%
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 10, 2024 Q1 2024 |
174,647
shares
|
$841,798
0.0% of portfolio
|
Q1 2024
Added 174.24%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 13, 2024 Q1 2024 |
173,700
shares
|
$837,234
0.0% of portfolio
|
Q1 2024
Reduced 20.5%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
May 13, 2024 Q1 2024 |
160,879
shares
|
$775,436
0.0% of portfolio
|
Q4 2023
Added 16.79%
|
|
Gsa Capital Partners LLP
London, X0 |
May 03, 2024 Q1 2024 |
131,098
shares
|
$631,892
0.08% of portfolio
|
Q1 2024
Reduced 21.5%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 08, 2024 Q1 2024 |
126,535
shares
|
$609,898
0.0% of portfolio
|
Q1 2024
Added 4.02%
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
124,246
shares
|
$598,865
0.0% of portfolio
|
Q1 2024
Added 7.59%
|
|
Superstring Capital Management LP
New York, NY |
May 15, 2024 Q1 2024 |
112,739
shares
|
$543,401
0.57% of portfolio
|
Q1 2024
Reduced 9.04%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
92,718
shares
|
$446,900
0.0% of portfolio
|
Q1 2024
Reduced 41.86%
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2024 Q1 2024 |
74,800
shares
|
$360,536
0.0% of portfolio
|
Q1 2024
Reduced 31.19%
|
|
Rhumbline Advisers
Boston, MA |
May 09, 2024 Q1 2024 |
63,137
shares
|
$304,320
0.0% of portfolio
|
Q1 2024
Added 4.72%
|
|
Prelude Capital Management, LLC
New York, NY |
May 15, 2024 Q1 2024 |
62,445
shares
|
$300,984
0.03% of portfolio
|
Q1 2024
New holding
|
|
Jpmorgan Chase & CO
New York, NY |
May 10, 2024 Q1 2024 |
61,577
shares
|
$296,801
0.0% of portfolio
|
Q1 2024
Added 79.34%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2024 Q1 2024 |
59,894
shares
|
$288,689
0.0% of portfolio
|
Q1 2024
Reduced 18.73%
|
|
American Century Companies Inc
Kansas City, MO |
May 14, 2024 Q1 2024 |
51,427
shares
|
$247,878
0.0% of portfolio
|
Q1 2024
Added 79.22%
|
|
Ubs Group Ag
|
May 13, 2024 Q1 2024 |
47,960
shares
|
$231,167
0.0% of portfolio
|
Q1 2024
Added 3.79%
|
|
Alps Advisors Inc
Denver, CO |
May 14, 2024 Q1 2024 |
43,560
shares
|
$209,959
0.0% of portfolio
|
Q1 2024
Added 3.19%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2024 Q1 2024 |
41,300
shares
|
$199,066
0.0% of portfolio
|
Q1 2024
Reduced 41.58%
|
|
Barclays PLC
London, X0 |
May 15, 2024 Q1 2024 |
36,909
shares
|
$177,901
0.0% of portfolio
|
Q1 2024
Reduced 46.6%
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
May 09, 2024 Q1 2024 |
34,832
shares
|
$167,890
0.0% of portfolio
|
Q1 2024
New holding
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 13, 2024 Q1 2024 |
31,380
shares
|
$151,251
0.0% of portfolio
|
Q1 2024
New holding
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 07, 2024 Q1 2024 |
30,154
shares
|
$145,342
0.0% of portfolio
|
Q1 2024
Reduced 30.93%
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2024 Q1 2024 |
29,893
shares
|
$144,084
0.0% of portfolio
|
Q1 2024
Reduced 44.33%
|